Hormone Replacement Therapy Comprising an Oestrogen-Progestogen Combination for Menopausal and Postmenopausal

Hormone replacement therapy comprising an oestrogen-progestogen combination for menopausal and postmenopausal women has been found to:

A) be inappropriate for the short-term relief associated with the clinical manifestations of the menopause.
B) lower the risk of cardiovascular disease in postmenopausal women.
C) reduce the relative risk of osteoporosis and colon cancer but increase the risk of breast cancer and thromboembolism for postmenopausal women receiving therapy.
D) be safer than the use of a selective oestrogen receptor modulator in the management of osteoporosis.